We would like to invite you to the Innovation Forum Cellular Allergy at BASEL LIFE 2019 on the 12th of September 2019 at the congress center in Basel.
- info@buhlmannlabs.ch
- +41 61 487 12 12
News
A very proactive patient in the UK suffering from Crohn`s disease wanted to share the story of his use of IBDoc® after one year.
The Mercy University Hospital in Cork was the first hospital to introduce the BÜHLMANN IBDoc® self-testing in routine. After 4 years of use they can show the real benefit of IBDoc® for patients and the clinic.
We are proud to announce the United States Food and Drug Administration (FDA) 510(k) clearance for the BÜHLMANN fCAL® turbo.
Social Links